Delivery Order SPE2DR25D6035-SPE2DR26FBLDG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,920.49 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 40 mg capsules in quantities of 30 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 26, 2025, issued on November 25, 2025. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 40 mg capsules (30-count units) with a ceiling value of $1,116.14. The contract was awarded on November 23, 2025, as a firm fixed-price delivery order with an ultimate completion date of November 24, 2025. This award represents a non-set-aside, competitively awarded transaction and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,537.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Isotretinoin 40 mg capsules (30-count packages). This non-set-aside contract is scheduled for completion by November 18, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply...
- The Defense Logistics Agency awarded a $1,040.60 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30. This firm fixed-price delivery order, which is scheduled for completion by November 13, 2025, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a child contract under AmerisourceBergen's larger federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $14,614.43 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 40 mg capsules in quantities of 30 units. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of December 15, 2025. The contract was issued on December 12, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $8,558.24 under firm fixed-price terms. The order is scheduled for completion by December 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is not set-aside and represents a competitive award, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Isotretinoin 40 mg capsules (30-count units) valued at $4,772.01. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 3, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Isotretinoin 40 mg capsules (30-count units) with a contract ceiling value of $2,945.39. This competitively awarded, firm fixed-price delivery order is set to conclude on October 22, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,269.27 for 30 mg Isotretinoin capsules (30-count supply) with an ultimate completion date of November 17, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D6035Indefinite Delivery Contract
- SPE2DR25D6035-SPE2DR26FBLDGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 40 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $3,159.36. The award was issued on December 13, 2025, with an ultimate completion date of December 15, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation. This award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, supplying an extensive range of pharmaceuticals and medical supplies to military and veteran healthcare systems. The company's established prime vendor relationship with the DLA enables flexible fulfillment of pharmaceutical needs across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 12/12/25 |